| |
|
|
Citizens Win Huge Supreme Court Victory over Big Pharma and the FDA |
 |
 |
 |
|
Written by Administrator
|
|
Saturday, 07 March 2009 13:06 |
Thursday, March 05, 2009
Byron Richards, CCN
In a stunning and unexpected 6-3 ruling the right-leaning Supreme Court went
against the wishes of the last president, took the wind out of the sails of
health care reform of the current president, sent irresponsible Big Pharma a
major wake up call, and bluntly told the arrogant FDA that they are indeed
not above the rule of law. It is a major victory for every American citizen
Central to the issue is a power a struggle between the federal government
and states, which in this situation meant the federal government authority
to pre-empt your state rights to sue if you are injured by a drug. The FDA,
acting on behalf of the Bush administration and on the side of Big Pharma,
has helped tie up thousands of drug injury lawsuits across the country. The
FDA, who is supposed to be protecting consumers from drug injury and
ensuring a correct risk/safety picture for any person taking a drug, was
instead trying to shirk their responsibility and simply claim that Americans
had no right to sue.
This convoluted attempt by the FDA to undermine consumer safety was one of
the main themes in my 2006 book, Fight for Your Health: Exposing the FDA’s
Betrayal of America. The Bush Administration had intentionally appointed
anti-safety people in high positions within the FDA, starting with its Chief
Counsel, Daniel Troy (and continued as a legal philosophy after Troy was
forced out for his Big Pharma connections). Troy set in motion the legal
problem the Supreme Court just decided.
During the final years of the Bush administration cancer industry insider
Andrew von Eschenbach, MD, was appointed to run the FDA, and Wall Street
insider, Scott Gottlieb, MD, was second in command. These individuals
sought to fully implement the FDA label as senior to any rights of citizens.
Their intention was to make sure that new biotech drugs would be protected
from lawsuits, as the FDA wanted to speed new and even more dangerous drugs
onto the market so as to foster the development of the biotech industry. In
essence, the FDA management wanted to turn the American public into one
large clinical experiment, with no right of recourse when injured.
This was occurring against a backdrop wherein the FDA couldn’t even name all
the drugs currently on the market, had failed to demand required aftermarket
follow up safety testing on drugs, and had intentionally withheld safety
information on existing drugs from the public. The current situation with
drugs is that almost no drug, even blockbusters and those in use for decades
have an accurate risk/benefit profile.
Americans who use medications are already taking risks of unknown magnitude,
which is a main reason over 100,000 Americans are killed every year and over
3 million are injured so seriously they need hospital care (ironically, over
half those injuries occur while already in the hospital).
The FDA knows full well that when a drug is approved for the market the full
extent of the side effects won’t be known for years. History shows us time
and again that Big Pharma actively hides risk data from the FDA and pays for
“science” that distorts reality. This irresponsible behavior goes along
with closed-door negotiations with the FDA, and has resulted in numerous
drug disasters like Vioxx. FDA managers oftentimes go against the wishes of
their own safety scientists and then move on to six figure salaries in the
industry they regulate. Doctors are not apprised of the actual risks and
consumers are in the dark.
Currently, there are 450,000 additional new cases of heart failure every
year in Americans over 65, a fact that parallels the increased use of
heart-weakening statins in this older group. It is only a matter of time
before the shoe drops on the 20-billion-dollar-a-year statin industry.
The FDA insistence that a drug label, based on what is known at the time of
approval, should supersede citizen’s states rights to sue if they were
injured, has almost nothing to do with consumer safety. Rather, it is a
federal power grab that is in the best financial interests of Big Pharma and
Big Biotech, industries that do not have consumer safety as their top
priority.
By the way, don’t think President Obama is on the side of the citizens. In
the health care section of the stimulus bill, there is specific pre-emption
language. If the federal government is in charge of health care it will be
named in future lawsuits when patients are injured from the care it doles
out or doesn’t allow.
The current Supreme Court ruling will undermine any system of federal health
care wherein the drugs being used are injuring people. Experts believe this
system is so badly broken, due to gross FDA management incompetence, that it
will take 10 years of studies and many billions of dollars just to
understand the actual risks of the drugs Americans are already taking.
In writing for the majority, Justice John Paul Stevens put Big Pharma on
notice. The defendant in this case, Wyeth, had argued that it could not
comply with both federal and state law. Stevens told them they had a
fundamental misunderstanding of regulation and were trying to hide behind
the FDA, going on to say that it is a central premise of federal drug
regulation that the manufacturer bears responsibility for the content of its
label at all times. That is not the news Big Pharma wanted to hear.
Stevens went on to write that there was no merit in the argument that the
FDA’s labeling decisions could supersede state law, saying that this
argument was “an untenable interpretation of congressional intent and an
overbroad view of an agency’s power to pre-empt state law.” He pointed out
that the FDA tried to push this on the public without any opportunity for
comment from the public or from states, all done against a backdrop wherein
the FDA is not able to keep up with safety issues in the first place,
meaning that the FDA position lacked “thoroughness, consistency and
persuasiveness.” Stevens stated that under such lacking standards the Bush
position “is entitled to no weight.”
This is a major victory for all Americans and for states. While the case
itself is on the topic of Big Pharma and the FDA, the ruling is sweeping in
nature and will extend far beyond prescription drugs. States have just been
handed a major legal ruling against the ever-growing incursion of federal
power.
|
|
|
